UCP2 and leukemia: In particular, over-expression of UCP2 has been reported in leukemia as well as in breast, colorectal, ovarian, bladder, esophagus, testicular, kidney, pancreatic, lung, and prostate cancer (Ayyasamy et al., 2011; Su et al., 2012).